Sugi Predict

Sugi Predict / Compounds / SCHEMBL1947890

SCHEMBL1947890

SCHEMBL1947890

CC(=O)ON(C(C)=O)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 1.00
▸ KMT2A Q03164 2/20 1.00
▸ ALOX15 P16050 1/20 1.00
▸ CA12 O43570 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA3 P07451 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA6 P23280 1/20 0.51
▸ CA5A P35218 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ CA13 Q8N1Q1 1/20 0.51
▸ CA14 Q9ULX7 1/20 0.51
▸ CA5B Q9Y2D0 1/20 0.51
▸ LMNA P02545 3/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MAPT P10636 4/20 0.42
▸ TP53 P04637 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643247 0.89 MEN1 (0.79) MEN1KMT2AALOX15CA12CA1
SCHEMBL1948599 0.83 KMT2A (0.71) MEN1KMT2AALOX15CA1CA2
SCHEMBL13039178 0.83 KMT2A (0.71) MEN1KMT2AALOX15CA12CA1
SCHEMBL29424354 0.82 MEN1 (0.69) MEN1KMT2AALOX15CA12CA1
SCHEMBL1947913 0.75 MEN1 (0.60) MEN1KMT2AALOX15LMNA
SCHEMBL7045570 0.75 CA1 (0.63) MEN1KMT2AALOX15CA12CA1
SCHEMBL1948848 0.74 MEN1 (0.59) MEN1KMT2AALOX15KDM4ECYP3A4
SCHEMBL27880968 0.69 KMT2A (0.53) MEN1KMT2AALOX15CA12CA1
SCHEMBL17225124 0.69 MEN1 (0.52) MEN1KMT2AALOX15CA12CA1
SCHEMBL11602365 0.69 ALOX15 (0.52) MEN1KMT2AALOX15CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220125745-A1 PHARMACEUTICAL COMPOSITION FOR CO-ADMINISTRATION OF ACIDOSIS-INDUCING DRUG HAIM BIO CO., LTD. (KR) 2022-04-28 — — US claimed
US-20220105053-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ACIDOSIS HAIM BIO CO., LTD. (KR) 2022-04-07 — — US claimed
CN-113543777-A Pharmaceutical composition for preventing or treating acidosis 哈林生物有限公司 2021-10-22 — — CN claimed
CN-113382727-A Pharmaceutical composition for administration in combination with acidosis-causing drug 哈林生物有限公司 2021-09-10 — — CN claimed
WO-2021141425-A1 PHARMACEUTICAL COMPOSITION, FOR PREVENTING AND TREATING HEMATOLOGICAL CANCER, COMPRISING BIGUANIDE-BASED COMPOUND AS ACTIVE INGREDIENT 주식회사 하임바이오 2021-07-15 — — WO claimed
CN-108963389-B Gelable system for lithium-air battery and preparation method and application thereof 北京师范大学 2020-11-13 — — CN claimed
WO-2020213938-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING SAPONIN AS ACTIVE INGREDIENT 주식회사 진센 2020-10-22 — — WO claimed
WO-2020213939-A1 PHARMACEUTICAL COMPOSITION FOR CO-ADMINISTRATION OF ANTICANCER DRUG 주식회사 진센 2020-10-22 — — WO claimed
EP-3637525-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR Beijing Normal University (CN) 2020-04-15 — — EP claimed
EP-3637524-A1 GELATINIZED SYSTEM AND APPLICATIONS IN LITHIUM AIR BATTERY, SUPER CAPACITOR OR CAPACITOR BATTERY IN ORGANIC SYSTEM Beijing Normal University (CN) 2020-04-15 — — EP claimed
US-20200099097-A1 GELABLE SYSTEM AND USES THEREOF IN LITHIUM-AIR BATTERIES, ORGANIC SUPERCAPACITORS OR CAPACITOR BATTERIES BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
US-20200099090-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND PREPARATION METHOD THEREOF BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
US-11557793-B2 Flexible all-solid-state lithium-ion secondary battery having gelable system containing lithium salt and ether compound, and preparation method thereof BEIJING NORMAL UNIVERSITY (CN) 2023-01-17 — — US disclosed
US-11545696-B2 Gelable system and uses thereof in lithium-air batteries, organic supercapacitors or capacitor batteries BEIJING NORMAL UNIVERSITY (CN) 2023-01-03 — — US disclosed
US-20220125745-A1 PHARMACEUTICAL COMPOSITION FOR CO-ADMINISTRATION OF ACIDOSIS-INDUCING DRUG HAIM BIO CO., LTD. (KR) 2022-04-28 — — US disclosed
US-20220105053-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ACIDOSIS HAIM BIO CO., LTD. (KR) 2022-04-07 — — US disclosed
EP-1863431-A1 HAIR AND/OR EYELASH CARE COMPOSITION CONTAINING AMINEXIL IN COMBINATION WITH AN AGENT FOR PROMOTING THE NO PRODUCTION AND USES THEREOF L'Oréal (FR) 2007-12-12 — — EP disclosed
WO-2006097359-A1 HAIR AND/OR EYELASH CARE COMPOSITION CONTAINING AMINEXIL IN COMBINATION WITH AN AGENT FOR PROMOTING THE NO PRODUCTION AND USES THEREOF L'ORÉAL (FR) 2006-09-21 — — WO disclosed
US-20030068386-A1 Method of treating cancerous disease PHROCURE, LLC 2003-04-10 — — US disclosed
WO-2003020221-A2 METHOD OF TREATING CANCEROUS DISEASE PHROCURE, LLC (US) 2003-03-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030068386-A1 Method of treating cancerous disease VHL, CD44, EGLN2 MEN1 394/4885KMT2A 1038/4885ALOX15 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.